Groups

Research Focus

Westchester; Per Diem RN

Recent additions – View all

1. Management of adverse events associated with cabozantinib plus nivolumab in advanced renal cell carcinoma

   Meeting Abstract

   Seery, V.; Andresen, D.; Martone, B.; Lee-Ramos, S.; Hall, T.; Virdee, K.
   Oncology Nursing Forum (2024)

   Fulltext@MSK | Save
2. The role of nurses in the management of adverse events in patients receiving first-line axitinib plus immuno-oncology agents for advanced renal cell carcinoma

   Review

   Parreira, S.; Burns, K.; Moldawer, N.; Zomordian, N.; Bandali, N.; Virdee, K.; Walsh, M.; Kelly, D.; Rao, D.; Teresi, R.; more...
   Seminars in Oncology Nursing (2024)

   Fulltext@MSK | Save
3. Avelumab first-line maintenance therapy: Managing patients with advanced urothelial carcinoma

   Review

   Lapuente, M.; Conway, D.; Wood, L. S.; Kehoe, K.; Bullock, A. C.; Devgan, G.; Burns, K. D.
   Clinical Journal of Oncology Nursing (2023)

   Fulltext@MSK | Save